| Application no. and date | 03791110.4 (espacenet) (Federated) (European Patent Register), 20030814 | | Patent/reg. no. and date | DK/EP 1594858, 20091014 | | Publication date | 20051116 | | Priority no. and date | US 406524 P, 20020828, US 417047 P, 20021008 | | EP pub. no. and date |
EP 1594858 20051116 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton,
Connecticut 06340, US | | Applicant ref. no. | P80904856DK00E | | Inventor | KATH, John, Charles,
Pfizer Global Res. and Dev., Eastern Point Road
Groton, CT 06340, US,
LYSSIKATOS, Joseph, Peter, 23 Estrella Avenue
Piedmont, CA 94611, US,
WANG, Huifen, Faye, Pfizer Global Research and Development
Groton, CT 06340, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/415 (2006.01) , A61P 35/00 (2006.01) , C07D 401/04 (2006.01) | | Title | Nye benzoimidazol-derivater, der kan anvendes som antiproliferative midler | | Int. application no. | IB2003003634 | | Int. publication no. | WO2004020431 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
